Trademark search for:

EVRALADE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2019-05-16 — Application filed
2019-07-18 — Sn assigned for sect 66a appl from ib
2019-07-19 — Application filed
2019-07-23 — Application filed
2019-08-01 — Assigned to examiner
2019-08-02 — Final disposition recorded
2019-08-03 — Office action issued
2019-08-27 — Office action issued
2019-08-27 — Office action issued
2019-09-13 — Office action issued
2019-10-02 — Teas/email correspondence entered
2019-10-02 — Office action issued
2019-10-02 — Correspondence received in law office
2019-10-08 — Approved for pub - principal register
2019-10-10 — Assigned to lie
2019-10-30 — Notification of possible opposition sent to ib
2019-10-30 — Notification of notice of publication e-mailed
2019-10-30 — Notice of start of opposition period created, to be sent to ib
2019-11-16 — Notification processed by ib
2019-11-19 — Published for opposition
2019-11-19 — Official gazette publication confirmation e-mailed
2019-12-02 — Final status recorded
2019-12-20 — Death of international registration
2019-12-21 — Notification of effect of cancellation of intl reg e-mailed

Owner Information

Glaxo Group Limited
GB

Correspondent

Merilee J. Arevalo GSK
5 MOORE DRIVE
LBP, 5.5A
RESEARCH TRIANGLE PARK, NC 27709-3398

Filing Details

Filing Date:
2019-05-16

Status Date:
2019-12-02

Category:
Pharmaceuticals

Filing Year:
2019

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.